The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China

References

• Baggen J, Thibaut HJ, Strating JRPM, et al. The life cycle of non-polio enteroviruses and how to target it. Nat Rev Microbiol. 2018;16:368–381. doi:https://doi.org/10.1038/s41579-018-0005-4
   PubMed Web of Science ®Google Scholar
• Xing W, Liao Q, Viboud C, et al. Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect Dis. 2014;14:308–318. doi:https://doi.org/10.1016/S1473-3099(13)70342-6
   PubMed Web of Science ®Google Scholar
• Solomon T, Lewthwaite P, Perera D, et al. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10:778–790. doi:https://doi.org/10.1016/s1473-3099(10)70194-8
   PubMed Web of Science ®Google Scholar
• Min N, Sakthi Vale PD, Wong AA, et al. Circulating salivary miRNA hsa-miR-221 as clinically validated diagnostic marker for hand, foot, and mouth disease in pediatric patients. EBioMedicine. 2018;31:299–206. doi:https://doi.org/10.1016/j.ebiom.2018.05.006
   Web of Science ®Google Scholar
• Feng H, Duan G, Zhang R, et al. Time series analysis of hand-foot-mouth disease hospitalization in Zhengzhou: establishment of forecasting models using climate variables as predictors. PloS One. 2014;9:e87916. doi:https://doi.org/10.1371/journal.pone.0087916
   Web of Science ®Google Scholar
• Lee BY, Wateska AR, Bailey RR, et al. Forecasting the economic value of an enterovirus 71 (EV71) vaccine. Vaccine. 2010;28:7731–7736. doi:https://doi.org/10.1016/j.vaccine.2010.09.065
   PubMed Web of Science ®Google Scholar
• Takahashi S, Liao Q, Van Boeckel TP, et al. Hand, foot, and mouth disease in China: modeling epidemic dynamics of enterovirus serotypes and implications for vaccination. PLoS Med. 2016;13:e1001958. doi:https://doi.org/10.1371/journal.pmed.1001958
   PubMed Web of Science ®Google Scholar
• Mclntyre MG, Stevens KM, Davidson S. Notes from the field: severe hand, foot, and mouth disease associated with coxsackievirus A6 – Alabama, Connecticut, California, and Nevada, November 2011–February 2012. MMWR Morbidity and Mort Wkly Rep. 2012;61:213–214.
   Google Scholar
• Yang F, Yuan J, Wang X, et al. Severe hand, foot, and mouth disease and coxsackievirus A6-shenzhen, China. Clin Infect Dis. 2014;59:1504–1505. doi:https://doi.org/10.1093/cid/ciu624
   PubMed Web of Science ®Google Scholar
• Hayman R, Shepherd M, Tarring C, et al. Outbreak of variant hand-foot-and-mouth disease caused by coxsackievirus A6 in Auckland, New Zealand. J Paediatr Child Health. 2014;50(10):751–755. doi:https://doi.org/10.1111/jpc.12708
   PubMed Web of Science ®Google Scholar
• Sinclair C, Gaunt E, Simmonds P, et al. Atypical hand, foot, and mouth disease associated with coxsackievirus A6 infection, Edinburgh, United Kingdom, January to February 2014. Euro Surveill. 2014;19:20745. es2014. 19.12.20745. doi:https://doi.org/10.2807/1560-7917
   PubMedGoogle Scholar
• Owino CO, Chu JJH. Recent advances on the role of host factors during non-poliovirus enteroviral infections. J Biomed Sci. 2019;26:47. doi:https://doi.org/10.1186/s12929-019-0540-y
   PubMed Web of Science ®Google Scholar
• Iturriza-Gómara M, Megson B, Gray J. Molecular detection and characterization of human enteroviruses directly from clinical samples using RT-PCR and DNA sequencing. J Med Virol. 2006;78:243–253. doi:https://doi.org/10.1002/jmv.20533
   PubMed Web of Science ®Google Scholar
• Blomqvist S, Klemola P, Kaijalainen S, et al. Co-circulation of coxsackieviruses A6 and A10 in hand, foot and mouth disease outbreak in Finland. J Clin Virol. 2010;48:49–54. doi:https://doi.org/10.1016/j.jcv.2010.02.002
   PubMed Web of Science ®Google Scholar
• Henquell C, Archimbaud C, Ughetto S, et al. Outbreak of hand, foot and mouth disease/herpangina associated with coxsackievirus A6 and A10 infections in 2010, France: a large citywide, prospective observational study. Clin Microbiol Infect. 2012;18:E110–E118. doi:https://doi.org/10.1111/j.1469-0691.2012.03789.x
   Web of Science ®Google Scholar
• Lu QB, Zhang XA, Wo Y, et al. Circulation of coxsackievirus A10 and A6 in hand-foot-mouth disease in China, 2009-2011. PLoS One. 2012;7:e52073. doi:https://doi.org/10.1371/journal.pone.0052073.
   PubMed Web of Science ®Google Scholar
• Yang Q, Ding J, Cao J, et al. Epidemiological and etiological characteristics of hand, foot, and mouth disease in Wuhan, China from 2012 to 2013: outbreaks of coxsackieviruses A10. J Med Virol. 2015;87:954–960. doi:https://doi.org/10.1371/journal.pone.0052073
   PubMed Web of Science ®Google Scholar
• Chen M, He S, Yan Q, et al. Severe hand, foot and mouth disease associated with coxsackievirus A10 infections in Xiamen, China in 2015. J Clin Virol. 2017;93:20–24. doi:https://doi.org/10.1016/j.jcv.2017.05.011
   PubMed Web of Science ®Google Scholar
• Alsop J, Flewett TH, Foster JR. “Hand-foot-and-mouth disease” in Birmingham in 1959. Br Med J. 1960;2:1708–1711. doi:https://doi.org/10.1136/bmj.2.5214.1708
   PubMed Web of Science ®Google Scholar
• Chan LG, Parashar UD, Lye MS, et al. Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, Malaysia: clinical and pathological characteristics of the disease. For the outbreak study group. Clin Infect Dis. 2000;31:678–683. doi:https://doi.org/10.1086/314032
   PubMed Web of Science ®Google Scholar
• Ho M, Chen ER, Hsu KH, et al. An epidemic of enterovirus 71 infection in Taiwan. Taiwan enterovirus epidemic working group. N Engl J Med. 1999;341:929–935. doi:https://doi.org/10.1056/NEJM199909233411301
   PubMed Web of Science ®Google Scholar
• Chan KP, Goh KT, Chong CY, et al. Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerging Infect Dis.. 2003;9:78–85. doi:https://doi.org/10.3201/eid0901.020112
   PubMed Web of Science ®Google Scholar
• Ji TJ, Han TL, Tan XJ, et al. Surveillance, epidemiology, and pathogen spectrum of hand, foot, and mouth disease in mainland of China from 2008 to 2017. Biosaf Health. 2019;1:32–40. doi:https://doi.org/10.1016/j.bsheal.2019.02.005
   Google Scholar
• Alexander JP, Baden L, Pallansch MA, et al. Enterovirus 71 infections and neurologic disease–United States, 1977-1991. J Infect Dis. 1994;169:905–908. doi:https://doi.org/10.1093/infdis/169.4.905
   PubMed Web of Science ®Google Scholar
• Guan D, van der Sanden S, Zeng H, et al. Population dynamics and genetic diversity of C4 strains of human enterovirus 71 in Mainland China, 1998-2010. PLoS One. 2012;7:e44386. doi:https://doi.org/10.1371/journal.pone.0044386
   Web of Science ®Google Scholar
• Gao L, Zou G, Liao Q, et al. Spectrum of enterovirus serotypes causing uncomplicated hand, foot, and mouth disease and enteroviral diagnostic yield of different clinical samples. Clin Infect Dis. 2018;67:1729–1735. doi:https://doi.org/10.1093/cid/ciy341
   PubMed Web of Science ®Google Scholar
• Mao Q, Wang Y, Shao J, et al. The compatibility of inactivated-enterovirus 71 vaccination with coxsackievirus A16 and poliovirus immunizations in humans and animals. Hum Vaccin Immunother. 2015;11:2723–2733. doi:https://doi.org/10.1080/21645515.2015.1011975
   PubMed Web of Science ®Google Scholar
• Zhang H, An D, Liu W, et al. Analysis of cross-reactive neutralizing antibodies in human HFMD serum with an EV71 pseudovirus-based assay. PLoS One. 2014;9:e100545. doi:https://doi.org/10.1371/journal.pone.0100545
   PubMed Web of Science ®Google Scholar
• Aswathyraj S, Arunkumar G, Alidjinou EK, et al. Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy. Med Microbiol Immunol. 2016;205:397–307. doi:https://doi.org/10.1007/s00430-016-0465-y
   PubMed Web of Science ®Google Scholar